Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. The Green Organic Dutchman Holdings Ltd.
  6. Summary
    TGOD   CA3932102088

THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.

(TGOD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
06/07/2021 06/08/2021 06/09/2021 06/10/2021 06/11/2021 Date
0.41(c) 0.41(c) 0.42(c) 0.385(c) 0.38(c) Last
1 827 642 1 018 214 1 129 391 3 031 073 2 398 208 Volume
+5.13% 0.00% +2.44% -8.33% -1.30% Change
More quotes
Financials
Sales 2021 38,0 M 31,3 M 31,3 M
Net income 2021 -12,0 M -9,87 M -9,87 M
Net Debt 2021 - - -
P/E ratio 2021 -19,0x
Yield 2021 -
Sales 2022 59,9 M 49,2 M 49,2 M
Net income 2022 -27,0 M -22,2 M -22,2 M
Net Debt 2022 - - -
P/E ratio 2022 -9,50x
Yield 2022 -
Capitalization 201 M 165 M 165 M
Capi. / Sales 2021 5,27x
Capi. / Sales 2022 3,35x
Nbr of Employees -
Free-Float 99,4%
More Financials
Company
Green Organic Dutchman Holdings Ltd is Canada-based company engaged in alternative medicine sector. The Company through its subsidiary, The Green Organic Dutchman Ltd (TGOD), holds the License issued by Health Canada pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR), which allows the Company to produce at its approximately 100 acre property near Hamilton, Ontario, dried marijuana, marijuana... 
Sector
Pharmaceuticals
Calendar
06/29 | 11:00amShareholder meeting
More about the company
Ratings of The Green Organic Dutchman Holdings Ltd.
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
06/11Cansortium Detail Shares for Debt Settlement
MT
06/11Columbia Care Up after Reporting Completion of Green Leaf Medical Purchase
MT
06/11SOCIAL BUZZ : Clover Health Retreats, Most Other Wallstreetbets Reddit Stocks Tr..
MT
06/10Creso Pharma Completes Dual Listing on US OTCQB Market; Shares Jump 13%
MT
06/10The Supreme Cannabis Shareholders Approve Proposed Sale to Canopy Growth
MT
06/10Flower One to Issue Common Shares to Satisfy Interest Payment Obligations Und..
MT
06/10Alliance Global Partners Initiates Coverage on IM Cannabis With Buy Rating, $..
MT
06/10Harborside Down after Reporting Settlement of Legal Spat with Former Staffer
MT
06/10Valens Joins Cannabis Council of Canada
MT
06/10Fire & Flower Holders Approve Share Consolidation In Preparation for Nasdaq L..
MT
06/10Dual Listed Neptune Wellness Solutions Launches Three New Cannabis Products i..
MT
06/10The Green Organic Dutchman Selling Quebec Facility to Cannara Biotech for Tot..
MT
06/09Auxly Cannabis Down 11.7% as Prices $15 Million Financing at $0.315 Per Unit
MT
06/09Aurora Cannabis Marketing Three New Dried-Flower Strains Developed at its Aur..
MT
06/09UPDATE : Neutrisci Rises 6% in Canada Trading on Shipment of Tabletz Rush Order ..
MT
More news
News in other languages on THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
06/10IRW-PRESS : Aleafia Health Inc.: Die weit verbreitete Cannabis-Marke Divvy von A..
06/10Trois actions pour avoir la main verte
06/09FLUJOS MINORISTAS HACIA "ACCIONES ME : Vanda Research
06/08IRW-PRESS : True Leaf Brands Inc.: Schreiben des CEO von True Leaf Brands Inc. a..
06/08IRW-PRESS : High Tide Inc.: High Tide gibt den Abbau vorrangig besicherter Schul..
More news
Analyst Recommendations on THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
More recommendations
Chart THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
Duration : Period :
The Green Organic Dutchman Holdings Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE GREEN ORGANIC DUTCHMAN HOLDINGS LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 1
Average target price 0,30 CAD
Last Close Price 0,38 CAD
Spread / Highest target -21,1%
Spread / Average Target -21,1%
Spread / Lowest Target -21,1%
EPS Revisions
Managers and Directors
NameTitle
Sean Bovingdon Chief Executive & Financial Officer
Jeffrey James Scott Chairman
Ravinder Kumar Chief Science Officer
Michel GagnÚ Chief Operating Officer
Nicholas G. Kirton Independent Director
Sector and Competitors